Zhong Guo Jing Ji Wang·2025-09-22 08:58Group 1 - The core point of the article is that ST Tian Sheng's stock is currently trading at 5.05 yuan, reflecting a decline of 3.07% and is in a state of breaking the issue price [1] - ST Tian Sheng was listed on the Shenzhen Stock Exchange's SME board on May 19, 2017, issuing 53 million shares at a price of 22.37 yuan per share, raising a total of 1.186 billion yuan [1] - The net amount raised after deducting issuance costs was 1.079 billion yuan, with specific allocations including 573 million yuan for GMP technology transformation of oral solid preparations, 199 million yuan for non-PVC soft bag large-volume injection GMP technology transformation, 209 million yuan for the Tian Sheng (Chongqing) modern pharmaceutical logistics headquarters, and 98.265 million yuan for the drug research and development center [1] Group 2 - The total issuance costs amounted to approximately 107 million yuan, which included 67.736 million yuan paid to Huaxi Securities for sponsorship and underwriting fees, 22.526 million yuan for legal fees to Beijing Mingshui Law Firm, and 5.08 million yuan for audit and verification fees to Beijing Xinghua Accounting Firm [1] - The issuance cost per share was 2.02 yuan [1]